Vyvanse 50 mg to Adderall Dose Conversion
The equivalent dose of Adderall for Vyvanse 50 mg is approximately 20 mg of Adderall, based on a conversion ratio of approximately 2.5:1 (Vyvanse:Adderall). 1
Conversion Algorithm
Apply a 2.5:1 conversion factor when switching from Vyvanse to Adderall:
- Vyvanse 50 mg ÷ 2.5 = Adderall 20 mg 1
- This conversion accounts for the fact that lisdexamfetamine (Vyvanse) is a prodrug that must be enzymatically converted to active dextroamphetamine in the body 2, 3
Pharmacokinetic Considerations
Vyvanse has a delayed onset but similar peak effects compared to immediate-release Adderall:
- Lisdexamfetamine produces amphetamine plasma levels with a 0.6-hour longer lag time and reaches peak concentrations approximately 1 hour later than equivalent doses of D-amphetamine 4
- Despite the delayed onset, the maximal plasma concentrations and total drug exposure (AUC) are equivalent between lisdexamfetamine and D-amphetamine at equimolar doses 4
- The prodrug mechanism results in rate-limited hydrolysis, gradually releasing active D-amphetamine throughout the day 3, 5
Dosing Framework
Standard dosing ranges support this conversion:
- Vyvanse starting dose: 20-30 mg once daily, titrated by 10 mg weekly increments to a maximum of 70 mg daily 6, 1
- Adderall starting dose: 10 mg once daily, titrated by 5 mg weekly increments up to 50 mg daily 6
- The 50 mg Vyvanse dose falls in the mid-therapeutic range, corresponding to the 20 mg Adderall mid-range dose 1
Clinical Caveats
Important differences to anticipate when converting:
- Vyvanse provides longer duration of action (up to 12-13 hours) compared to immediate-release Adderall (4-6 hours), so patients may need twice-daily Adderall dosing to maintain symptom control throughout the day 7, 2
- Peak subjective effects occur later with Vyvanse but are similar in magnitude to Adderall at equivalent doses 4
- No washout period is required when switching between these medications as they work through the same mechanism (once converted to active amphetamine) 8
Monitor for differences in symptom control timing: